1 A Public Health and Human Rights Imperative: The Case for Prison Needle and Syringe Programs XVII International AIDS Conference Tuesday, August 5, 2008.

Slides:



Advertisements
Similar presentations
The Health in Prisons Programme HIPP of WHO Why does WHO engage in prison health?
Advertisements

Needle and syringe programmes in prisons
1 A handbook on HIV, law and human rights for the judiciary: A critical tool in a human rights-based HIV response Richard Elliott, Alison Symington and.
Advocacy 1. What is Advocacy? ● Organized effort to influence policy change/decision making ● Action directed at changing approach of an individual/institution/group.
1 Safe Cells: building the case for prison needle and syringe programs in Canada Canadian Congress on Criminal Justice October 3 rd, 2013 Sandra Ka Hon.
Key Stakeholders In Humanitarian Assistance Humanitarian Assistance refers the assistance given to a group of people during/affected by calamity or disaster.
In prison drugs do not enter! that's what the authorities mostly say… Daniela De Santis Prevention coordinator Switzerland January 2014.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
A Call for Action HIV/AIDS & Hepatitis C in Irish Prisons Irish Penal Reform Trust & Merchants Quay Ireland by Rick Lines, MA July 26, 2002.
1 On Point: making prison needle and syringe programs work in Canada January 23rd, 2014 Sandra Ka Hon Chu Canadian HIV/AIDS Legal Network.
Harm Reduction in Prisons: Prisoners’ Rights are Human Rights Rick Lines, MA Executive Director, Irish Penal Reform Trust December 11 th 2003.
Living with HIV Know Your Rights Privacy and health records The information contained in this publication is information about the law, but it is not legal.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Health as a human right: The treatment of persons in institutional care settings Presenter: Carol Berry Solicitor, Public Interest Advocacy Centre © PIAC.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
Treatment of drug addiction in prisons
Legal Aid: A Right or a Privilege?. 2 + Sources of international law right to legal aid Scope of international law right to legal aid Canada’s duty to.
Dilemmas in the treatment of HIV and Hepatitis C in Canadian prisons.
At the frontier of drug harm reduction Prisoners’ rights to health & safety David McDonald Visiting Fellow National Centre for Epidemiology and Population.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Privacy Codes of Conduct as a self- regulatory approach to cope with restrictions on transborder data flow Dr. Anja Miedbrodt Exemplified with the help.
Sharing Session- 17 th Annual International Conference on the Reduction of Drug-Related Harm NIGERIA CANADAPAKISTANBRAZIL.
Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Essential package of targeted interventions for MARA Romania Experience.
Firenze, 27 March |1 | HIV and HCV in prisons: From evidence to action Firenze, ICAR 2011, 27 March 2011 Ralf Jürgens, Canada.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Resource Needs Model Rachel Sanders October 28 th, 2010.
1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.
CIVIL RIGHTS & ADA West Texas Opportunities, Inc September 27, 2012.
Harm Reduction International
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
International Network of Treatment and Rehabilitation Resource Centres Prevention, Treatment and Rehabilitation Unit Global Challenges Section.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
Skills Building Workshop – Conducting Situation and Needs Assessments in Prison Settings HIV and AIDS in Prisons Overview of Issues and Challenges Brian.
The Canadian Correctional Public Health Program Prison Health Expert Group Sixth Meeting Oslo, Norway September 30, 2008.
Health in Prisons Project Oslo, 24 November 2009 Lars Moller Regional Adviser a.i. World Health Organization Regional Office for Europe Health in Prisons.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Universal Access Charter The Universal Access Charter is intended to be the voice of communities and civil societies around the world; The Charter is a.
HIV Prevention, Treatment and Care in Prison Settings: Public Health and Human Rights Approach AIDS 2016 Conference Durban, South Africa 20 July 2016 Ehab.
1 Barriers to access to sterile syringes in Canada: legal, policy and human rights issues XVI International AIDS conference Tuesday, 15 August 2006 Alana.
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Thai AIDS Treatment Action Group (TTAG)
General Situation (Overview)
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
Addressing Drug Use Together Through a Health Based Approach:
Motivating Prisoners’ Access to Condoms in Southern Africa
People who inject drugs
Access to Services in Prison and Beyond
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Towards a Conducive Legal and Structural Environment
Harm reduction friend or foe?
Human Dignity and Harm Reduction
Presentation transcript:

1 A Public Health and Human Rights Imperative: The Case for Prison Needle and Syringe Programs XVII International AIDS Conference Tuesday, August 5, 2008 Sandra Ka Hon Chu Senior Policy Analyst Canadian HIV/AIDS Legal Network

2 About the Canadian HIV/AIDS Legal Network The Canadian HIV/AIDS Legal Network ( promotes the human rights of people living with and vulnerable to HIV/AIDS, in Canada and internationally, through research, legal and policy analysis, education, and community mobilization. The Legal Network is Canada’s leading advocacy organization working on the legal and human rights issues raised by HIV/AIDS.

3 Acknowledgments  Rick Lines  Ralf Jürgens  Glenn Betteridge  Heino Stover  Dumitru Laticevschi  Joachin Nelles  Richard Elliott

4 Issue  In Canada and many other countries, the prevalence of HIV and hepatitis C (HCV) in prison populations is much higher than in the population as a whole.  A survey by the Correctional Service of Canada revealed that 38 percent of federal prisoners reported having used drugs since arriving at their current institution and 11 percent reported drug use by injection.  Because of the scarcity of needles and syringes in prison, people who inject drugs in prison are more likely to share injecting equipment than people in the community, thereby increasing the risk of contracting HIV and HCV.

5 Objective and Methods Undertake the first comprehensive review of prison needle and syringe programs (PNSPs) worldwide through:  a review of existing Canadian and international literature  site visits to PNSPs in Moldova, Switzerland, Germany, and Spain  personal communications with staff and funders of PNSPs in Kyrgyzstan and Belarus  legal analysis based on Canadian and international law

6 Results We produced a comprehensive review of:  what is known about HIV/AIDS, HCV and IDU in prisons worldwide  the experiences of six countries that have introduced PNSPs  international and Canadian law regarding access to harm reduction in prisons  what this means for implementation of PNSPs in Canada

7 Results

8 As of August 2008, PNSPs have been introduced in over 60 prisons in at least eleven countries: SwitzerlandBelarus GermanyArmenia SpainLuxembourg MoldovaIran PortugalRomania Kyrgyzstan

9 Results PNSPs are operating in:  well-funded prison systems and severely under-funded prison systems  civilian prison systems and military prison systems  institutions with drastically different physical arrangements for the housing of prisoners  men’s and women’s institutions and  prisons of all security classifications and all sizes

10 Results PNSPs utilize various methods for distributing syringes:  hand-to-hand exchange by nurses and/or the prison physician  distribution by one-for-one automated syringe dispensing machines  distribution by prisoners trained as peer outreach workers  distribution by external NGOs or other health professionals

11 Results PrisonIncidence of HIV/HCVNeedle SharingDrug UseInjection Am Hasenburg No dataStrongly reducedNo increase Basauri No seroconversionStrongly reducedNo increase Hannoversand No dataStrongly reducedNo increase Hindelbank No seroconversionStrongly reducedDecreaseNo increase Berlin (Lehrter Strasse et Lichtenburg) Strongly reducedNo increase Lingen 1 No seroconversionStrongly reducedNo increase Realta No seroconversionSingle casesDecreaseNo increase Vechta No seroconversionStrongly reducedNo increase Vierlande No seroconversion Little change or no reduction No increase

12 Results Feared negative consequences have not materialized: “In no case needles have been used as weapons. … Inmates involved in the NEP are required to keep their kit in a pre- determined location in their cells. This assists the staff when they enter the cell to conduct cell searches. Because syringes and needles are an approved program, there is no need for an offender to conceal them in their cells.”

13 Results Evaluations have also shown:  improvement in the health of prisoners

14 Results Determinants of success:  PNSP must suit the needs of the institution, the prisoner population, and the prison staff  Confidential and easy access  PNSP should be one component of broader health strategy  Support of prison administration and staff is crucial  Start with a number of pilot projects that are evaluated

15 Results Under international law, persons in detention also explicitly retain: The right to the highest attainable standard of health; The right to equality in the enjoyment of human rights (except insofar as necessarily limited by incarceration); and The right to life.

16 Results Principle of Retaining Rights: prisoners retain all civil rights that are not taken away expressly or by necessary implication as a result of the loss of liberty flowing from imprisonment Principle of equivalence: entitles persons in detention to a standard of health care equal to that available outside of prisons and includes preventative measures requires standards that achieve equivalent health objectives

17 Results People in prison also have the right to preventative health measures. Providing sterile syringes to prisoners to help prevent the spread of blood-borne viruses has been considered and supported by numerous international organisations, including the WHO, UNAIDS, the Office of the UN High Commissioner on Human Rights and UNODC.

18 Results In Canada, the federal government has a statutory obligation under the Correctional and Conditional Release Act (“CCRA”) to provide prisoners with essential health care akin to that available in the community. Both the principle of retaining rights and the principle of equivalence are reflected in the CCRA. Accordingly, bleach is available in all federal correctional facilities to “promote public health and a safe and healthy environment…as a harm reduction measure against the transmission of HIV and other infectious diseases.” In the community, Health Canada in 2001 reported that there were over 200 needle and syringe programs in the country, yet the possession of needles or syringes are prohibited in prisons and could lead to a disciplinary offence.

19 Results The failure of federal authorities to provide PNSPs may also contravene the Canadian Charter of Rights and Freedoms (“Charter”). The Charter guarantees the right: to life, liberty and security of the person (section 7); not to be subjected to any cruel and unusual treatment or punishment (section 12); and to equality before and under the law (section 15).

20 Lessons learned Prison authorities’ failure to provide prisoners with access to essential HIV and HCV prevention measures: violates their human right to the highest attainable of health and the principles of retaining rights and equivalence in prison health care; is inconsistent with international instruments dealing with prisoners’ rights, prison health services and HIV/AIDS in prisons; and may be a violation of prisoners’ rights under the Charter.

21 Conclusions  PNSPs have proven safe and effective in every jurisdiction where they have been introduced and are effective in promoting and protecting prisoners’ health.  There are no valid reasons not to introduce PNSPs in Canada.  Pilot PNSPs should be established in all regions of CSC (and in a number of provincial institutions).

22

23 Canadian HIV/AIDS Legal Network 1240 Bay Street, Suite 600 Toronto, Ontario Canada M5R 2A7 Telephone: Fax: Website: